Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.04 CAD
Change Today 0.00 / 0.00%
Volume 105.0K
As of 1:25 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark W. Dewhirst DVM,Ph.D.

Member of the Scientific Advisory Board, Medifocus Inc.
AgeTotal Calculated CompensationThis person is connected to 22 board members in 3 different organizations across 3 different industries.

See Board Relationships


Dr. Mark W. Dewhirst, DVM, PhD, is a Professor in the Department of Radiation Oncology at the Duke University Medical Centre. Dr. Dewhirst is an internationally recognized leader in hyperthermic therapy, and the Gustavo S. Montana Professor of Radiation Oncology and Director of the Radiation Oncology Program of the Duke Comprehensive Cancer Center. Dr. Dewhirst serves as the Editor-in-Chief of the International Journal of Hyperthermia. Dr. Dewhirst served as either a ...

Read Full Background

Corporate Headquarters*

The Exchange Tower
Toronto, Ontario M5X 1E3


Phone: 905-319-7070
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MFS:CN C$0.04 CAD 0.00


Gregory J. Fluet Chief Executive Officer, Interim Chief Financial Officer and Director
Urologix, Inc.
Michael H. Tardugno Chairman, Chief Executive Officer and President
Celsion Corp.
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
Michael F. Mahoney Chief Executive Officer, President and Director
Boston Scientific Corporation
Magnus Bolmsjö Chief Executive Officer and Director
ProstaLund AB (publ)
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIFOCUS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at